Dana-Farber initiative will require pre-emptive genetic testing before 5-FU and/or capecitabine By fishnyc22|2023-02-22T15:15:55-05:00February 22, 2023|Uncategorized|
NCODA publishes a Positive Quality Intervention recommending screening for DPD/DPYD prior to the use of fluoropyrimidine based chemotherapy By fishnyc22|2021-12-20T11:23:10-05:00December 20, 2021|Best Practices|
